Laboratory Corp. (LH) Tops Q2 EPS by 3c; Reaffirms FY11 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- US stock futures rise as investors assess Democrats' midterm sweep
- CVS Health plans to split into two public companies by 2028
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
Tweet
Share
E-mailGet Alerts LH Hot Sheet
Join SI Premium – FREE
Laboratory Corp. (NYSE: LH) reported Q2 EPS of $1.64, $0.03 better than the analyst estimate of $1.61. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.39 billion.
Reaffirms outlook.
Reaffirms outlook.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Flutter Entertainment plc (FLUT) Misses Q3 EPS by 525c; lowers guidance
- Bruker (BRKR) Tops Q3 EPS by 14c; offers guidance
- SelectQuote, Inc. (SLQT) Tops Q1 EPS by 13c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
